Skip to content

Clinical trials

Recruiting Carcinoma, Non-Small-Cell Lung trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Recruiting Country / region: Taiwan Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20193
20203
20215
20226
20239
202418
202524
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting87

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC11
AstraZeneca9
Bristol-Myers Squibb6
AbbVie5
Pfizer5
National Taiwan University Hospital4
Pierre Fabre Medicament4
DualityBio Inc.3
Daiichi Sankyo2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung87
Lung Neoplasms24
Neoplasms9
Squamous Cell Carcinoma of Head and Neck8
Carcinoma7
Carcinoma, Hepatocellular5
Melanoma5
Stomach Neoplasms5
Breast Neoplasms4
Head and Neck Neoplasms4

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.